US Stock MarketDetailed Quotes

BEAM Beam Therapeutics

Watchlist
  • 26.800
  • -0.280-1.03%
Close Jan 8 16:00 ET
2.22BMarket Cap-16.96P/E (TTM)

Beam Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beam Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.461M--
--2024/Q4-- / 15.654M--
Nov 5, 20242024/Q314.269M / 14.132M--
--2024/Q211.772M / 13.047M--
--2024/Q17.410M / 14.664M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.461M--
--2024/Q4-- / 15.654M--
Nov 5, 20242024/Q314.269M / 14.132M--
--2024/Q211.772M / 13.047M--
--2024/Q17.410M / 14.664M--

Unlock Free Earnings Estimates

Beam Therapeutics Earnings Reports

  • Beam Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 5, 2024 09:11 ET

  • Beam Therapeutics | 8-K: Beam Therapeutics Reports Third Quarter 2024 Financial Results and Progress Across Priority Programs

    Nov 5, 2024 07:06 ET

  • Beam Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6, 2024 08:58 ET

  • Beam Therapeutics | 8-K: Beam Therapeutics Reports Pipeline Updates and Second Quarter 2024 Financial Results

    Aug 6, 2024 07:13 ET

    • Read more

    Trending US Stocks
    Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

    Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

    Symbol Mini Chart % Chg
    Toll Brothers
    TOL
    +2.56%
    Meritage Homes
    MTH
    +2.34%
    Taylor Morrison Home
    TMHC
    +1.58%
    D.R. Horton
    DHI
    +1.49%
    KB Home
    KBH
    +1.35%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 9, 2025

    Buy

    • Buy

      73.33%

    • Hold

      26.67%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Gene Editing
    Gene Editing
    Intraday+0.30%
    ARK Portfolio
    ARK Portfolio
    Intraday-0.33%